Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human prostacyclin receptor.

Emer M Smyth1, Garret A FitzGerald

  • 1Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

Vitamins and Hormones
|December 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantifying sleep wake rhythms in the hospital environment with digital technologies.

NPJ digital medicine·2026
Same author

Comparing the quantitation of specialized pro-resolving mediators in plasma and serum using ELISA and LC-MS/MS.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same author

TracMyAir: Smartphone-enabled spatiotemporal estimates for inhaled doses of particulate matter and ozone to personalize health outcomes.

medRxiv : the preprint server for health sciences·2026
Same author

Depression of tryptophan may contribute to adverse effects of naproxen.

Nature communications·2026
Same author

Age and the Diurnal Oscillatory Features of the Human Chronobiome.

medRxiv : the preprint server for health sciences·2026
Same author

Concomitant COX-1 and COX-2 suppression is not sufficient to induce enteropathy associated with chronic NSAID use.

The Journal of clinical investigation·2026
Same journal

Bilateral macronodular and micronodular hyperplasia: Biochemical, radiological and genetic diagnosis.

Vitamins and hormones·2026
Same journal

ACTH independent Cushing's syndrome: Diagnosis and etiology.

Vitamins and hormones·2026
Same journal

Biochemical diagnosis of hypercortisolism: When and how?

Vitamins and hormones·2026
Same journal

New tools for the diagnosis of hypercortisolism.

Vitamins and hormones·2026
Same journal

Cardiometabolic comorbidities in overt Cushing's syndrome.

Vitamins and hormones·2026
Same journal

Molecular profile of Cushing's syndrome.

Vitamins and hormones·2026
See all related articles

Prostacyclin (PGI2) is a key lipid mediator with vasodilator and antiplatelet effects, acting via the IP receptor. This review explores IP receptor signaling, regulation, and its biological roles.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Prostacyclin (PGI2) is a crucial eicosanoid derived from arachidonic acid metabolism in vascular endothelium.
  • It functions as a potent vasodilator, antithrombotic, and antiplatelet agent.
  • These effects are mediated through its specific receptor, known as the IP receptor.

Purpose of the Study:

  • To review the current understanding of the IP receptor.
  • To examine the signaling pathways and regulatory mechanisms of the IP receptor.
  • To discuss the biological roles of prostacyclin and its receptor in vivo and explore potential multiple receptor sites.

Main Methods:

  • Literature review and synthesis of existing research on prostacyclin and the IP receptor.
  • Analysis of cDNA cloning data for the IP receptor from various species.

Related Experiment Videos

  • Examination of studies investigating IP receptor signaling, regulation, and in vivo functions.

    • Main Results:

    • The IP receptor belongs to the G protein-coupled receptor superfamily.
    • Cloning of IP receptor cDNA has enabled detailed study of its signaling and regulatory pathways.
    • Prostacyclin plays significant roles in vascular homeostasis, and the existence of multiple PGI2 receptor sites is under investigation.

    Conclusions:

    • The IP receptor is a well-characterized G protein-coupled receptor involved in prostacyclin's biological actions.
    • Further research is warranted to fully elucidate the complexities of IP receptor signaling, regulation, and potential multiplicity.
    • Understanding the IP receptor is critical for developing targeted therapies for cardiovascular and thrombotic disorders.